General Information of Drug Off-Target (DOT) (ID: OTFOA92Z)

DOT Name Putative adrenomedullin-5-like protein (ADM5)
Gene Name ADM5
Related Disease
Advanced cancer ( )
UniProt ID
ADM5_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MTIHILILLLLLAFSAQGDLDTAARRGQHQVPQHRGHVCYLGVCRTHRLAEIIYWIRCLH
QGALGEGQPRAPGPLQLWAPPVARGGSPARFPGFRPAARGLAQCPARWVTSGTARPLLGF
SLPICMLELLLHISSPLTPAPETVFPSPSPGCD
Function Probable non-functional remnant of adrenomedullin-5.

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Altered Expression [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Putative adrenomedullin-5-like protein (ADM5). [2]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Putative adrenomedullin-5-like protein (ADM5). [7]
------------------------------------------------------------------------------------
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Putative adrenomedullin-5-like protein (ADM5). [3]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Putative adrenomedullin-5-like protein (ADM5). [4]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Putative adrenomedullin-5-like protein (ADM5). [5]
Methotrexate DM2TEOL Approved Methotrexate decreases the expression of Putative adrenomedullin-5-like protein (ADM5). [6]
------------------------------------------------------------------------------------

References

1 Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.Gene. 2016 Oct 30;592(1):78-85. doi: 10.1016/j.gene.2016.07.042. Epub 2016 Jul 20.
2 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
3 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
4 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
5 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
6 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.